Abstract
Some patients with more severe disorders of gut-brain interaction (DGBI) will fail to improve with gut-directed therapies and dietary change. Some of them will require use of central neuromodulators, and many will benefit from psychological therapies. The importance of a biopsychosocial model for functional gastrointestinal disorders is discussed. The significance of anxiety, depression, and early life trauma in determining the severity of functional GI disorders is reviewed. The incidence of psychiatric abnormalities in patients with IBS and other FGIDs is examined. The benefit of different psychological therapies for managing DBGIs is evaluated.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Engel GL. The need for a new medical model: a challenge for biomedicine. Science. 1977;196:129. https://doi.org/10.1126/science.847460.
Drossman DA. Presidential address: gastrointestinal illness and the biopsychosocial model. Psychosom Med. 1998;60:258. https://doi.org/10.1097/00006842-199805000-00007.
Tanaka Y, Kanazawa M, Fukudo S, Drossman DA. Biopsychosocial model of irritable bowel syndrome. J Neurogastroenterol Motil. 2011;17(2):131–9. https://doi.org/10.5056/jnm.2011.17.2.131.
Bennett EJ, Tennant CC, Piesse C, Badcock CA, Kellow JE. Level of chronic life stress predicts clinical outcome in irritable bowel syndrome. Gut. 1998;43:256. https://doi.org/10.1136/gut.43.2.256.
Walker LS, Garber J, Smith CA, Van Slyke DA, Claar RL. The relation of daily stressors to somatic and emotional symptoms in children with and without recurrent abdominal pain. J Consult Clin Psychol. 2001;69:85. https://doi.org/10.1037/0022-006X.69.1.85.
Mayer EA. The neurobiology of stress and gastrointestinal disease. Gut. 2000;47:861. https://doi.org/10.1136/gut.47.6.861.
Ford MJ, Miller PM, Eastwood J, Eastwood MA. Life events, psychiatric illness and the irritable bowel syndrome. Gut. 1987;28:160. https://doi.org/10.1136/gut.28.2.160.
Creed F, Guthrie E. Psychological factors in the irritable bowel syndrome. Gut. 1987;28:1307. https://doi.org/10.1136/gut.28.10.1307.
Toner BB, Garfinkel PE, Jeejeebhoy KN. Psychological factors in irritable bowel syndrome. Can J Psychiatr. 1990;35:158.
Osterberg E, Blomquist L, Krakau I, Weinryb RM, Asberg M, Hultcrantz R. A population study on irritable bowel syndrome and mental health. Scand J Gastroenterol. 2000;35(3):264–8.
Whitehead WE, Palsson O, Jones KR. Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications? Gastroenterology. 2002;122:1140. https://doi.org/10.1053/gast.2002.32392.
Lydiard RB. Irritable bowel syndrome, anxiety, and depression: what are the links? J Clin Psychiatry. 2001;62(Suppl 8):38–45; discussion 46–7. http://www.ncbi.nlm.nih.gov/pubmed/12108820. Accessed 28 Aug 2016.
Lee S, Wu J, Ma YL, Tsang A, Guo W-J, Sung J. Research article: irritable bowel syndrome is strongly associated with generalized anxiety disorder: a community study. Aliment Pharmacol Ther. 2009;30:643. https://doi.org/10.1111/j.1365-2036.2009.04074.x.
Drossman DA, Leserman J, Nachman G, et al. Sexual and physical abuse in women with functional or organic gastrointestinal disorders. Ann Intern Med. 1990;113(11):828–33.
Leserman J, Drossman DA, Li Z, Toomey TC, Nachman G, Glogau L. Sexual and physical abuse history in gastroenterology practice: how types of abuse impact health status. Psychosom Med. 1996;58:4. https://doi.org/10.1097/00006842-199601000-00002.
Drossman DA. Abuse, trauma, and GI illness: is there a link. Am J Gastroenterol. 2011;106:14. https://doi.org/10.1038/ajg.2010.453.
Walker EA, Katon WJ, Roy-Byrne PP, Jemelka RP, Russo J. Histories of sexual victimization in patients with irritable bowel syndrome or inflammatory bowel disease. Am J Psychiatry. 1993;150:1502. https://doi.org/10.1176/ajp.150.10.1502.
Lackner JM, Brasel AM, Quigley BM, et al. The ties that bind: perceived social support, stress, and IBS in severely affected patients. Neurogastroenterol Motil. 2010;22:893. https://doi.org/10.1111/j.1365-2982.2010.01516.x.
Drossman DA, Whitehead WE, Toner BB, et al. What determines severity among patients with painful functional bowel disorders? Am J Gastroenterol. 2000;95:974. https://doi.org/10.1016/S0002-9270(00)00728-0.
Van Oudenhove L, Levy RL, Crowell MD, et al. Biopsychosocial aspects of functional gastrointestinal disorders: how central and environmental processes contribute to the development and expression of functional gastrointestinal disorders. Gastroenterology. 2016;150(6):1355–1367e2. https://doi.org/10.1053/j.gastro.2016.02.027.
Neal KR, Barker L, Spiller RC. Prognosis in post-infective irritable bowel syndrome: a six year follow up study. Gut. 2002;51:410. https://doi.org/10.1136/gut.51.3.410.
Levy RL, Whitehead WE, Walker LS, et al. Increased somatic complaints and health-care utilization in children: effects of parent IBS status and parent response to gastrointestinal symptoms. Am J Gastroenterol. 2004;99:2442. https://doi.org/10.1111/j.1572-0241.2004.40478.x.
Drossman DA. Redux: do little bellyachers grow up to become big bellyachers? Clin Gastroenterol Hepatol. 2014;12:2033. https://doi.org/10.1016/j.cgh.2014.06.009.
Drossman DA, Leserman J, Li Z, Keefe F, Hu YJ, Toomey TC. Effects of coping on health outcome among women with gastrointestinal disorders. Psychosom Med. 2000;62:309. https://doi.org/10.1097/00006842-200005000-00004.
Drossman DA, McKee DC, Sandler RS, et al. Psychosocial factors in the irritable bowel syndrome. A multivariate study of patients and nonpatients with irritable bowel syndrome. Gastroenterology. 1988;95(3):701–8.
Young SJ, Alpers DH, Norland CC, Woodruff RA. Psychiatric illness and the irritable bowel syndrome. Practical implications for the primary physician. Gastroenterology. 1976;70(2):162–6.
Sperber AD, Drossman DA. Review article: the functional abdominal pain syndrome. Aliment Pharmacol Ther. 2011;33(5):514–24. https://doi.org/10.1111/j.1365-2036.2010.04561.x.
Törnblom H, Drossman DA. Centrally targeted pharmacotherapy for chronic abdominal pain. Neurogastroenterol Motil. 2015;27(4):455–67. https://doi.org/10.1111/nmo.12509.
Mayer EA, Tillisch K. The brain-gut axis in abdominal pain syndromes. Annu Rev Med. 2011;62:381–96. https://doi.org/10.1146/annurev-med-012309-103958.
Drossman DA, Ringel Y, Vogt BA, et al. Alterations of brain activity associated with resolution of emotional distress and pain in a case of severe irritable bowel syndrome. Gastroenterology. 2003;124:754. https://doi.org/10.1053/gast.2003.50103.
Seminowicz DA, Labus JS, Bueller JA, et al. Regional gray matter density changes in brains of patients with irritable bowel syndrome. Gastroenterology. 2010;139(1):48–57.e2. https://doi.org/10.1053/j.gastro.2010.03.049.
Jones MP, Dilley JB, Drossman D, Crowell MD. Brain-gut connections in functional GI disorders: anatomic and physiologic relationships. Neurogastroenterol Motil. 2006;18:91. https://doi.org/10.1111/j.1365-2982.2005.00730.x.
Dekel R, Drossman DA, Sperber AD. The use of psychotropic drugs in irritable bowel syndrome. Expert Opin Investig Drugs. 2013;22(3):329–39. https://doi.org/10.1517/13543784.2013.761205.
Dorn SD, Palsson OS, Thiwan SIM, et al. Increased colonic pain sensitivity in irritable bowel syndrome is the result of an increased tendency to report pain rather than increased neurosensory sensitivity. Gut. 2007;56(9):1202–9. https://doi.org/10.1136/gut.2006.117390.
Clouse RE, Lustman PJ. Use of psychopharmacological agents for functional gastrointestinal disorders. Gut. 2005;54(9):1332–41. https://doi.org/10.1136/gut.2004.048884.
Lackner JM, Ma CX, Keefer L, et al. Type, rather than number, of mental and physical comorbidities increases the severity of symptoms in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol. 2013;11:1147. https://doi.org/10.1016/j.cgh.2013.03.011.
Sperber AD, Dekel R. Irritable bowel syndrome and co-morbid gastrointestinal and extra-gastrointestinal functional syndromes. J Neurogastroenterol Motil. 2010;16:113. https://doi.org/10.5056/jnm.2010.16.2.113.
Ford AC, Quigley EMM, Lacy BE, et al. Effect of antidepressants and psychological therapies, including hypnotherapy, in irritable bowel syndrome: systematic review and meta-analysis. Am J Gastroenterol. 2014;109(9):1350–65; quiz 1366. https://doi.org/10.1038/ajg.2014.148.
Lackner JM, Mesmer C, Morley S, Dowzer C, Hamilton S. Psychological treatments for irritable bowel syndrome: a systematic review and meta-analysis. J Consult Clin Psychol. 2004;72:1100. https://doi.org/10.1037/0022-006X.72.6.1100.
Lydiard RB, Greenwald S, Weissman MM, Johnson J, Drossman DA, Ballenger JC. Panic disorder and gastrointestinal symptoms: findings from the NIMH Epidemiologic Catchment Area project. Am J Psychiatry. 1994;151:64. https://doi.org/10.1176/ajp.151.1.64.
Spiegel BMR, Khanna D, Bolus R, Agarwal N, Khanna P, Chang L. Understanding gastrointestinal distress: a framework for clinical practice. Am J Gastroenterol. 2011;106:380. https://doi.org/10.1038/ajg.2010.383.
Levy RL, Langer SL, Walker LS, et al. Cognitive-behavioral therapy for children with functional abdominal pain and their parents decreases pain and other symptoms. Am J Gastroenterol. 2010;105:946. https://doi.org/10.1038/ajg.2010.106.
Toner BB, Segal ZV, Emmott S, et al. Cognitive-behavioral group therapy for patients with irritable bowel syndrome. Int J Group Psychother. 1998;48:215.
Hunt MG. Reclaim your life from IBS. New York: Sterling; 2016.
Keefer L. Extinguishing fear of gastrointestinal symptoms to treat functional gastrointestinal disorders. Clin Gastroenterol Hepatol. 2016;14:1559. https://doi.org/10.1016/j.cgh.2016.07.004.
Bremner JD. Does stress damage the brain. Biol Psychiatry. 1999;45:797. https://doi.org/10.1016/S0006-3223(99)00009-8.
Perera TD, Park S, Nemirovskaya Y. Cognitive role of neurogenesis in depression and antidepressant treatment. Neuroscientist. 2008;14:326. https://doi.org/10.1177/1073858408317242.
Brunoni AR, Lopes M, Fregni F. A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression. Int J Neuropsychopharmacol. 2008;11(8):1169–80. https://doi.org/10.1017/S1461145708009309.
Blankstein U, Chen J, Diamant NE, Davis KD. Altered brain structure in irritable bowel syndrome: potential contributions of pre-existing and disease-driven factors. Gastroenterology. 2010;138(5):1783–9. https://doi.org/10.1053/j.gastro.2009.12.043.
Mayer EA, Brunnhuber S. Gastrointestinal disorders. Handb Clin Neurol. 2012;106:607–31. https://doi.org/10.1016/B978-0-444-52002-9.00036-X.
Drossman DA. Functional gastrointestinal disorders: history, pathophysiology, clinical features, and Rome IV. Gastroenterology. 2016;150:1262. https://doi.org/10.1053/j.gastro.2016.02.032.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Sobin, W.H. (2019). The Gut-Brain Connection and Its Significance to Gastroenterologists. In: Sobin, W. (eds) Using Central Neuromodulators and Psychological Therapies to Manage Patients with Disorders of Gut-Brain Interaction. Springer, Cham. https://doi.org/10.1007/978-3-030-18218-2_1
Download citation
DOI: https://doi.org/10.1007/978-3-030-18218-2_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-18217-5
Online ISBN: 978-3-030-18218-2
eBook Packages: MedicineMedicine (R0)